Hospital Infection Control & Prevention – October 1, 2017
October 1, 2017
View Archives Issues
-
Highly Drug-resistant C. auris Continues to Emerge in U.S.
The CDC is urging infection preventionists and their clinical colleagues to have a high index of suspicion for emerging Candida auris, a fungus that spreads more like bacteria, can be highly drug-resistant, and survives on skin and environmental surfaces for prolonged periods.
-
SSIs: A Common and Costly Infection
The CDC has issued new guidelines for the prevention of the most common and costly healthcare-associated infection: surgical site infections.
-
CMS, Joint Commission Are Citing for ‘Flash’ Sterilization
The abiding principle is that if you must rapidly sterilize an instrument — usually in an effort to return it to the sterile field — you must immediately use it.
-
Poor Oral Care During Hospitalization May Lead to Pneumonia
Ventilator-associated pneumonia is a commonly tracked healthcare-associated infection, and frequently the target of interventions to protect patients. On the other hand, non-ventilator healthcare-associated pneumonia falls into a gray area, where it often remains unreported in surveillance systems.
-
Virulent, Drug-resistant Pneumonia Bug Emerges in China ICU
In particularly unwelcome news from China, researchers report they have isolated a strain of Klebsiella pneumoniae that is both hypervirulent and highly drug-resistant. A worse combination is difficult to imagine. Usually, hypervirulent K. pneumoniae remains susceptible to drugs, but acquiring resistance apparently through genetic transfer in nature means this is a bug that could possibly infect heathy people in the community, let alone frail hospital patients.